Diclofenac Diethylamine + Oleum Lini + Methyl SalicylateThird Party Manufacturing in India

This topical combination works through three complementary mechanisms to provide effective relief from localized pain and inflammation.

Diclofenac diethylamine is a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase-1 and cyclooxygenase-2 enzymes, reducing the synthesis of prostaglandins and other inflammatory mediators. It preferentially inhibits COX-2 at the site of inflammation and also blocks the lipoxygenase pathway, decreasing leukotriene B4 production. Topical application delivers diclofenac directly to the affected tissues with minimal systemic absorption, achieving therapeutic concentrations in synovial fluid and periarticular structures while avoiding gastrointestinal side effects associated with oral NSAIDs.

Methyl salicylate acts as a counterirritant and topical analgesic. It is absorbed through the skin and hydrolyzed to salicylic acid, which provides mild anti-inflammatory and analgesic effects at the local tissue level. Its rubefacient action increases blood flow to the application area, producing a warming sensation that helps relieve underlying muscle and joint discomfort.

Oleum Lini (linseed oil) serves as an emollient and skin conditioning agent in the formulation. Rich in omega-3 fatty acids, it helps maintain skin barrier function, facilitates drug penetration through the stratum corneum, and soothes the skin at the application site. Its natural composition makes it a well-tolerated vehicle for the active pharmaceutical ingredients.

Therapeutic Uses

Diclofenac Diethylamine + Oleum Lini + Methyl Salicylate topical gel is indicated for the treatment of:

• Musculoskeletal Pain: For relief of localized pain and inflammation associated with sprains, strains, and soft tissue injuries. The combination provides both rapid symptomatic relief and sustained anti-inflammatory action.
• Osteoarthritis Pain: For symptomatic management of osteoarthritis in superficial joints such as the knees, hands, and elbows. Topical application targets the affected joint directly with reduced systemic exposure compared to oral NSAIDs.
• Rheumatic Pain: As an adjunct in the management of localized rheumatic conditions where topical NSAID therapy is appropriate, particularly for patients who cannot tolerate oral NSAIDs due to gastrointestinal or cardiovascular concerns.
• Sports Injuries: For acute and subacute sports-related injuries including muscle pulls, ligament sprains, and tendonitis where rapid onset of pain relief is needed at the site of injury.
• Back Pain: For localized muscular back pain and lumbago when applied directly to the affected area, providing targeted relief without systemic sedation.

Why Manufacturers Choose This Combination

This triple-action topical gel is a high-demand product in the Indian pharmaceutical market due to its differentiated mechanism combining an NSAID, a counterirritant, and a natural emollient in a single formulation. It offers PCD franchise partners and contract manufacturers a product with strong retail demand across general medicine, orthopedic, and sports medicine practices.

The manufacturing process for this topical gel is well-established in WHO-GMP certified facilities across India. Major production hubs in Himachal Pradesh, Gujarat, and Uttarakhand routinely manufacture this combination using standard topical manufacturing equipment. The formulation offers flexibility in packaging options from aluminium tubes to laminated pouches. With consistent year-round demand and a proven safety profile that supports over-the-counter availability in many markets, this combination is a valuable addition to any third party manufacturing portfolio in India.